BRPI0606658A2 - método para distribuir interferon-beta - Google Patents

método para distribuir interferon-beta

Info

Publication number
BRPI0606658A2
BRPI0606658A2 BRPI0606658-5A BRPI0606658A BRPI0606658A2 BR PI0606658 A2 BRPI0606658 A2 BR PI0606658A2 BR PI0606658 A BRPI0606658 A BR PI0606658A BR PI0606658 A2 BRPI0606658 A2 BR PI0606658A2
Authority
BR
Brazil
Prior art keywords
interferon
distributing
beta
reduces
solution
Prior art date
Application number
BRPI0606658-5A
Other languages
English (en)
Inventor
Eric Anthony Faulkner
Mary Diana Di Biase
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36601194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0606658(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Publication of BRPI0606658A2 publication Critical patent/BRPI0606658A2/pt
Publication of BRPI0606658A8 publication Critical patent/BRPI0606658A8/pt
Publication of BRPI0606658B1 publication Critical patent/BRPI0606658B1/pt
Publication of BRPI0606658B8 publication Critical patent/BRPI0606658B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

MéTODO PARA DISTRIBUIR INTERFERON-BETA. A presente invenção refere-se a um método aqui descrito reduz a quantidade de metal agregante liberado em uma solução de Interferon-<225>.
BRPI0606658A 2005-01-12 2006-01-11 método para armazenar e distribuir interferon-beta, e dispositivo BRPI0606658B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64327305P 2005-01-12 2005-01-12
US60/643,273 2005-01-12
PCT/US2006/001016 WO2006076453A2 (en) 2005-01-12 2006-01-11 METHOD FOR DELIVERING INTERFERON-β

Publications (4)

Publication Number Publication Date
BRPI0606658A2 true BRPI0606658A2 (pt) 2009-07-07
BRPI0606658A8 BRPI0606658A8 (pt) 2017-02-14
BRPI0606658B1 BRPI0606658B1 (pt) 2021-03-09
BRPI0606658B8 BRPI0606658B8 (pt) 2021-05-25

Family

ID=36601194

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606658A BRPI0606658B8 (pt) 2005-01-12 2006-01-11 método para armazenar e distribuir interferon-beta, e dispositivo

Country Status (19)

Country Link
US (3) US8784399B2 (pt)
EP (1) EP1845925B1 (pt)
JP (2) JP5192823B2 (pt)
KR (1) KR101238148B1 (pt)
CN (2) CN101102739B (pt)
AU (2) AU2006204937B2 (pt)
BR (1) BRPI0606658B8 (pt)
CA (1) CA2594894C (pt)
CY (1) CY1118097T1 (pt)
DK (1) DK1845925T3 (pt)
ES (1) ES2588583T3 (pt)
HU (1) HUE031061T2 (pt)
IL (2) IL184372A (pt)
LT (1) LT1845925T (pt)
MX (1) MX2007008220A (pt)
PL (1) PL1845925T3 (pt)
PT (1) PT1845925T (pt)
SG (1) SG158872A1 (pt)
WO (1) WO2006076453A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1845925T3 (pl) 2005-01-12 2017-05-31 Biogen Ma Inc. Sposób podawania interferonu beta

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266557A (en) 1978-01-16 1981-05-12 The Kendall Company Low friction syringe
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US4521237A (en) 1983-05-23 1985-06-04 Kahle Engineering Co. Glass dose syringe
CN85201778U (zh) 1985-04-30 1986-04-16 欧阳士波 全自动的注射器清洗设备
US5183746A (en) 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US4895716A (en) 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US5011608A (en) * 1988-11-18 1991-04-30 Dragana Damjanovic Biogenic amine assay using HPLC-ECD
CN2076853U (zh) 1990-06-15 1991-05-15 阎淑华 多孔式注射器清洗架
KR0138353Y1 (ko) 1996-12-13 1999-04-01 주식회사부윤테크 일회용 주사기
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
IL130524A (en) * 1996-12-24 2005-08-31 Biogen Idec Inc Stable liquid interferon formulations, a kit containing the same and a process for stabilizing the same
EP2253548A1 (en) 1998-03-13 2010-11-24 Becton, Dickinson and Company Method for manufacturing, filling and packaging medical containers
JP2951938B1 (ja) * 1998-03-19 1999-09-20 日本ケミカルリサーチ株式会社 薬剤溶解機構を内蔵した注射器
CN100480266C (zh) 1998-10-16 2009-04-22 拜奥根Idec马萨诸塞公司 干扰素-β融合蛋白及用途
DE19903876B4 (de) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten
AU780270B2 (en) * 2000-02-23 2005-03-10 Association Francaise Contre Les Myopathies Treatment of immune diseases
JP4492985B2 (ja) 2000-02-24 2010-06-30 三菱商事プラスチック株式会社 液体医薬品用プラスチック容器及び液体医薬品の保存回収方法
WO2003000322A1 (en) * 2001-06-20 2003-01-03 Becton, Dickinson And Company Safety shield system for prefilled syringes
WO2004002500A1 (en) * 2002-06-28 2004-01-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
AR044302A1 (es) * 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
EP1809579B1 (en) * 2004-09-30 2012-08-08 Becton, Dickinson and Company Method for reducing or eliminating residue in a glass medical container and container made in accordance therewith
PL1845925T3 (pl) 2005-01-12 2017-05-31 Biogen Ma Inc. Sposób podawania interferonu beta
CA2619452A1 (en) * 2005-09-12 2007-03-22 Alza Corporation Coatable transdermal delivery microprojection assembly

Also Published As

Publication number Publication date
US8784399B2 (en) 2014-07-22
JP2011252026A (ja) 2011-12-15
IL184372A (en) 2016-02-29
WO2006076453A2 (en) 2006-07-20
JP2008526441A (ja) 2008-07-24
KR101238148B1 (ko) 2013-03-04
AU2011202152A1 (en) 2011-06-02
CN101102739A (zh) 2008-01-09
MX2007008220A (es) 2007-08-17
IL243648A0 (en) 2016-02-29
AU2006204937B2 (en) 2011-02-10
KR20070102545A (ko) 2007-10-18
US20080188823A1 (en) 2008-08-07
US20160361389A1 (en) 2016-12-15
CN107028760A (zh) 2017-08-11
ES2588583T3 (es) 2016-11-03
CN107028760B (zh) 2019-11-01
BRPI0606658B8 (pt) 2021-05-25
EP1845925B1 (en) 2016-08-24
US9452106B2 (en) 2016-09-27
CY1118097T1 (el) 2017-06-28
CA2594894C (en) 2015-11-03
IL184372A0 (en) 2007-10-31
SG158872A1 (en) 2010-02-26
CN101102739B (zh) 2017-02-08
CA2594894A1 (en) 2006-07-20
AU2006204937A1 (en) 2006-07-20
US10220074B2 (en) 2019-03-05
HUE031061T2 (en) 2017-06-28
PL1845925T3 (pl) 2017-05-31
WO2006076453A3 (en) 2006-09-21
BRPI0606658B1 (pt) 2021-03-09
US20150080840A1 (en) 2015-03-19
PT1845925T (pt) 2016-11-22
LT1845925T (lt) 2016-09-26
BRPI0606658A8 (pt) 2017-02-14
JP5192823B2 (ja) 2013-05-08
EP1845925A2 (en) 2007-10-24
DK1845925T3 (en) 2016-11-28

Similar Documents

Publication Publication Date Title
SG171584A1 (en) Nanoparticulate metal boride composition and its use for identification- marking plastic parts
TW200714283A (en) Method and composition for treating peripheral vascular diseases
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
SG149884A1 (en) Low sulfur metal detergent-dispersants
EP1754175A4 (en) OCCASIONALLY ASSOCIATED APPLICATION SERVER
UA94088C2 (ru) Композиция с ингибирующим действием по отношению к уреазе и способ ее получения
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
TW200801813A (en) Resist composition and pattern forming method using the same
PL2578081T3 (pl) Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
IL184135A0 (en) Target design for high-power laser acceleratrd ions
MX2009004132A (es) Composiciones para contrarrestar el mal olor.
CR10257A (es) &#34;método para inducir la tolerancia de plantas contra bacteriosis&#34;
SG127854A1 (en) Improved gold electrolytes
SG143149A1 (en) Phosphite composition and method for producing the same
ZA200707407B (en) Composition for preventing plant diseases and method for preventing the diseases
PL2092009T3 (pl) Utwardzalne promieniowaniem zestawy, zawierające kwas krzemowy, o podwyższonej ochronie przeciwkorozyjnej na podłożach metalowych
GB0506554D0 (en) Components-structure management system for repair components
MEP10209A (en) Stable emulsion composition
EP1991248A4 (en) ANTIDEPRESSANT PRODRUGS
BRPI0518580A2 (pt) mÉtodo para melhorar a depuraÇço hepÁtica de substÂncias xenobiàticas em um animal, kit adequado para alimentar Ácido lipàico a um animal, meio para comunicar informaÇço, composiÇço, e, uso da composiÇço que compreende Ácido lipàico
EP1829540A4 (en) COMPOSITION FOR THE PREVENTION / TREATMENT OF LIVER DISEASES
SG131953A1 (en) Carbon containing sputter target alloy compositions
BRPI0606658A2 (pt) método para distribuir interferon-beta
TW200619875A (en) Compositions comprising tannic acid as corrosion inhibitor
TW200505460A (en) Rosmarinic acid composition

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: BIOGEN MA INC. (US)

B25I Requirement for requested change of headquarter

Owner name: BIOGEN MA INC. (US)

B25G Requested change of headquarter approved

Owner name: BIOGEN MA INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/01/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF